EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject:"Fluorouracil"
Narrow search

Narrow search

Year of publication
Subject
All
Fluorouracil 10 Antineoplastics 6 Pharmacoeconomics 5 Cost-effectiveness 4 Colorectal cancer 3 Colorectal-cancer 3 Cost-analysis 3 Cyclophosphamide 3 Folinic-acid 3 Raltitrexed 3 Bevacizumab 2 Capecitabine 2 Folinic acid 2 Granulocyte-colony-stimulating-factors 2 Irinotecan 2 Oxaliplatin 2 Tegafur/uracil 2 5-Fluorouracil 1 Administration schedule 1 Advanced-breast-cancer 1 Anthracyclines 1 Bone-marrow-transplant 1 Breast-cancer 1 Cetuximab 1 Chemotherapy-induced-anaemia 1 Cisplatin 1 Cost analysis 1 Cost-minimisation 1 Cost-utility 1 Costs 1 Decision-making 1 Doxorubicin 1 Early-breast-cancer 1 Epirubicin 1 Etoposide 1 Filgrastim 1 Gemcitabine 1 Levamisole 1 Melphalan 1 Methotrexate 1
more ... less ...
Online availability
All
Undetermined 11
Type of publication
All
Article 11
Language
All
Undetermined 11
Author
All
Aristides, Mike 2 Asche, Carl 1 Barron, Richard L. 1 Botwood, Nick 1 Bracco-Nolin, Claire-Hélène 1 Brouwers, Jacobus R.B.J. 1 Chaigneau, Loic 1 Chen, Jack 1 Chia, Victoria M. 1 Clarke, Stephen 1 Cripps, Christine 1 Danese, Mark D. 1 Delozier, Thierry 1 Fabbro, Michel 1 Gleeson, Michelle L. 1 Grant, Kaye 1 Griffiths, Robert I. 1 Heyes, Anne 1 Huchet, Bernard 1 Jansman, Frank G.A. 1 Janvier, Maud 1 Konig, Hans-Helmut 1 Le Corroller, Anne-Gaelle 1 Lees, Michael 1 Legat-Fagnoni, Christine 1 Legg, Jason C. 1 Leidl, Reiner 1 Letarte, Jacques 1 Limat, Samuel 1 Link, Karl-Heinrich 1 Livartowski, Alain 1 Lyman, Gary H. 1 Maniadakis, Nikos 1 Marino, Patricia 1 Maroun, Jean A. 1 McKendrick, Jan 1 Moatti, Jean-Paul 1 Molinier, Laurent 1 Monz, Brigitta U.M. 1 Mukherjee, Jayanti 1
more ... less ...
Published in...
All
PharmacoEconomics 9 The European Journal of Health Economics 2
Source
All
RePEc 11
Showing 1 - 10 of 11
Cover Image
Bevacizumab for Metastatic Colorectal Cancer: A NICE Single Technology Appraisal
Whyte, Sophie; Pandor, Abdullah; Stevenson, Matt - In: PharmacoEconomics 30 (2012) 12, pp. 1119-1132
the non-inferiority of oxaliplatin plus capecitabine (XELOX) compared with oxaliplatin plus 5-fluorouracil and folinic … oxaliplatin and either 5-fluorouracil plus folinic acid or capecitabine (i.e. FOLFOX or XELOX) was not recommended for the …
Persistent link: https://www.econbiz.de/10010614306
Saved in:
Cover Image
Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer
Griffiths, Robert I.; Barron, Richard L.; Gleeson, … - In: PharmacoEconomics 30 (2012) 2, pp. 103-118
epirubicin); cyclophosphamide (C); taxane ([T]: paclitaxel or docetaxel); and fluorouracil (F). Patients were …
Persistent link: https://www.econbiz.de/10010614316
Saved in:
Cover Image
Cost Considerations in the Treatment of Colorectal Cancer
Jansman, Frank G.A.; Postma, Maarten J.; Brouwers, … - In: PharmacoEconomics 25 (2007) 7, pp. 537-562
colorectal cancer. The survival benefits of chemotherapy are only modest. For nearly 5 decades, 5-fluorouracil (5-FU) has been …
Persistent link: https://www.econbiz.de/10005243196
Saved in:
Cover Image
Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer
Limat, Samuel; Bracco-Nolin, Claire-Hélène; … - In: The European Journal of Health Economics 7 (2006) 2, pp. 107-113
Persistent link: https://www.econbiz.de/10005615775
Saved in:
Cover Image
Q-TWiST Analysis of Cyclophosphamide, Epirubicin, Fluorouracil versus Cyclophosphamide, Methotrexate, Fluorouracil Treatment for Premenopausal Women with Node-Positive Breast Cance...
Radice, Davide; Redaelli, Alberto - In: PharmacoEconomics 23 (2005) 1, pp. 69-75
axillary node-positive breast cancer receiving either cyclophosphamide, epirubicin and fluorouracil (CEF) or cyclophosphamide …, methotrexate, and fluorouracil (CMF), using data from a phase III clinical trial (National Cancer Institute of Canada Clinical …
Persistent link: https://www.econbiz.de/10005404873
Saved in:
Cover Image
A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada
Maroun, Jean A.; Asche, Carl; Romeyer, Francoise; … - In: PharmacoEconomics 21 (2003) 14, pp. 1039-1051
Background: Two randomised, controlled trials (n = 1396) comparing (i) intravenous fluorouracil (FU) plus oral folinic …
Persistent link: https://www.econbiz.de/10005404878
Saved in:
Cover Image
Cost Effectiveness of Adding Folinic Acid to Fluorouracil Plus Levamisole as Adjuvant Chemotherapy in Patients with Colon Cancer in Germany
Monz, Brigitta U.M.; Konig, Hans-Helmut; Leidl, Reiner; … - In: PharmacoEconomics 21 (2003) 10, pp. 709-719
Objective: To assess the cost effectiveness of the addition of folinic acid to fluorouracil plus levamisole in patients … fluorouracil plus levamisole (A, standard) or fluorouracil plus levamisole and folinic acid (B) for 12 months as adjuvant …: Adding folinic acid to the fluorouracil/levamisole regimen results in an increase in time to progression and survival in …
Persistent link: https://www.econbiz.de/10005590340
Saved in:
Cover Image
Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer
Marino, Patricia; Le Corroller, Anne-Gaelle; Palangie, Thao - In: PharmacoEconomics 21 (2003) 11, pp. 807-818
Objective: To evaluate the potential cost savings of using sequential high dose chemotherapy (HDC), with granulocyte colony-stimulating factor (filgrastim) and stem cell support, rather than single course administration of HDC with bone marrow transplantation (BMT) or peripheral blood stem cell...
Persistent link: https://www.econbiz.de/10005590492
Saved in:
Cover Image
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK
Aristides, Mike; Lees, Michael; Botwood, Nick; … - In: The European Journal of Health Economics 4 (2003) 3, pp. 216-221
Persistent link: https://www.econbiz.de/10009404272
Saved in:
Cover Image
Conjoint Analysis of a New Chemotherapy: Willingness to Pay and Preference for the Features of Raltitrexed versus Standard Therapy in Advanced Colorectal Cancer
Aristides, Mike; Chen, Jack; Schulz, Mark; Williamson, Eve - In: PharmacoEconomics 20 (2002) 11, pp. 775-784
therapy with fluorouracil plus leucovorin (FU-LV) from the perspective of patients with advanced colorectal cancer. The study …
Persistent link: https://www.econbiz.de/10005590404
Saved in:
  • 1
  • 2
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...